» Articles » PMID: 19017860

Mortality Rates and Diabetic Foot Ulcers: is It Time to Communicate Mortality Risk to Patients with Diabetic Foot Ulceration?

Overview
Date 2008 Nov 20
PMID 19017860
Citations 80
Authors
Affiliations
Soon will be listed here.
Abstract

Five-year mortality rates after new-onset diabetic ulceration have been reported between 43% and 55% and up to 74% for patients with lower-extremity amputation. These rates are higher than those for several types of cancer including prostate, breast, colon, and Hodgkin's disease. These alarmingly high 5-year mortality rates should be addressed more aggressively by patients and providers alike. Cardiovascular diseases represent the major causal factor, and early preventive interventions to improve life expectancy in this most vulnerable patient cohort are essential. New-onset diabetic foot ulcers should be considered a marker for significantly increased mortality and should be aggressively managed locally, systemically, and psychologically.

Citing Articles

Guided Conditional Diffusion Classifier (ConDiff) for Enhanced Prediction of Infection in Diabetic Foot Ulcers.

Busaranuvong P, Agu E, Kumar D, Gautam S, Fard R, Tulu B IEEE Open J Eng Med Biol. 2024; 6:20-27.

PMID: 39564561 PMC: 11573405. DOI: 10.1109/OJEMB.2024.3453060.


Knowledge and practice of foot self-care behaviours in Irish diabetes patients with high-risk feet.

Algethami A, Mustafa M, Lockhart M, Reilly L, McKearney E, Fortune K Ir J Med Sci. 2024; 193(6):2791-2796.

PMID: 39320704 DOI: 10.1007/s11845-024-03807-1.


Conservative surgery in the management of diabetic foot complications (excluding Charcot). The role of the orthopedic surgeon.

Yammine K J Clin Orthop Trauma. 2024; 55:102513.

PMID: 39228922 PMC: 11367647. DOI: 10.1016/j.jcot.2024.102513.


Effect of Ozone Therapy on Diabetes-related Foot Ulcer Outcomes: A Systematic Review and Meta-analysis.

Izadi M, Jafari-Oori M, Eftekhari Z, Jafari N, Maybodi M, Heydari S Curr Pharm Des. 2024; 30(27):2152-2166.

PMID: 38982924 DOI: 10.2174/0113816128302890240521065453.


Growth factors and growth factor gene therapies for treating chronic wounds.

Mullin J, Rahmani E, Kiick K, Sullivan M Bioeng Transl Med. 2024; 9(3):e10642.

PMID: 38818118 PMC: 11135157. DOI: 10.1002/btm2.10642.